Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-053971

Director sold 14,916 shares at $35.00 ($522,060)

  • Director acquired 14,916 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GRIFFIN MICHELLE RENEE · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-27 Exercise or conversion : show line 1 in the form +14,916 $7.80 $116,345 16,420 D
2021-08-27 Sale : show line 2 in the form −14,916 $35.00 $522,060 1,504 D
Open-market sales · 14,916 sh · avg $35.00 · $522,060

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-27 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −14,916 52,084 D
Loading xslF345X03/doc4.xml…